CLINICAL_TRIALS ClinicalTrials.gov record update

Safety & Immunogenicity of a Booster Dose of dTPa Vaccine (Boostrix®) Co-admnd. With Aventis Pasteur's Meningococcal (Serogroups A, C, Y and W-135) Polysaccharide Vaccine (Menactra™) vs Admn. of Either Vaccine Alone in Healthy Adolescents

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00282295
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:49.545600+00:00
Published At: 2017-03-16T00:00:00+00:00
Record Updated At: 2018-08-17
Results Posted At: 2017-03-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acellular Pertussis", "Tetanus", "Diphtheria"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-08-17"
protocolSection.identificationModule.nctId: "NCT00282295"
protocolSection.identificationModule.officialTitle: "Safety \u0026 Immunogenicity of a Booster Dose of dTPa Vaccine (Boostrix\u00ae) Co-admnd. With Aventis Pasteur\u0027s Meningococcal (Serogroups A, C, Y and W-135) Polysaccharide Vaccine (Menactra\u2122) vs Admn. of Either Vaccine Alone in Healthy Adolescents"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-03-16"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.